What Is ZBH Fair Value?
Zimmer Biomet (ZBH) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Zimmer Biomet (ZBH) has a composite fair value estimate of $122.42 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $91.77, suggesting the stock is undervalued by 33.4%.
Data as of October 14, 2026 (today)
Composite Fair Value
Undervalued3 of 4 models$122.42
vs. current price of $91.77(+33.4%)
How Is ZBH Fair Value Calculated?
Four independent models estimate what ZBH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
ZBH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$132.44
+44.3%Undervalued
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
ZBH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$112.77
+22.9%Undervalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$85.34
-7.0%Fair Value
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $91.77 is 44.3% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.13B | $1.06B |
| Year 2 | $1.18B | $1.05B |
| Year 3 | $1.24B | $1.04B |
| Year 4 | $1.31B | $1.03B |
| Year 5 | $1.37B | $1.02B |
| Year 6 | $1.44B | $1.01B |
| Year 7 | $1.52B | $994.9M |
| Year 8 | $1.59B | $984.3M |
| Year 9 | $1.67B | $973.9M |
| Year 10 | $1.76B | $963.5M |
| Terminal Value | $48.77B | $26.74B |
What Are ZBH's Key Financial Metrics?
Earnings & Growth
Current Price
$91.77
EPS (TTM)
$4.12
Forward P/E
10.1
Profit Margin
9.5%
Cash & Balance Sheet
Free Cash Flow
1.1B
EBITDA
2.5B
Book Value
$66.23
Total Debt
7.6B
What Do Analysts Say About ZBH?
Low
$93.00
Average
$106.82
High
$130.00
Upside
+16.4%
ZBH Fair Value FAQ
What is the fair value of ZBH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), ZBH's estimated fair value is $122.42. The stock is currently trading at $91.77, which makes it undervalued by our analysis.
How is ZBH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is ZBH overvalued or undervalued?
Based on our analysis, ZBH is undervalued. The current price of $91.77 is 33.4% below our estimated fair value of $122.42.
What do Wall Street analysts say about ZBH?
22 analysts cover Zimmer Biomet with a consensus rating of "Buy." The average price target is $106.82, ranging from $93.00 to $130.00. This implies 16.4% upside from the current price.